ProCE Banner Activity

Best Practices for Type 2 Diabetes Management: Update on Guidelines and New Treatment Advances

Multimedia
Vivian A. Fonseca, MD, FRCP, discusses best practices for the management of type 2 diabetes based on the latest guidelines and emerging treatment approaches.

Released: August 04, 2016

Expiration: August 03, 2017

No longer available for credit.

Share

Faculty

Vivian A. Fonseca

Vivian A. Fonseca, MD, FRCP

Professor of Medicine and Pharmacology
Assistant Dean for Clinical Research
Tullis Tulane Alumni Chair in Diabetes
Chief, Section of Endocrinology
Tulane University Health Sciences center
New Orleans, Louisiana

Provided by

Provided by the Endocrine Society, in collaboration with Clinical Care Options.
ProCE Banner

Supporters

Supported by educational grants from

Merck Human Health HIV

Novo Nordisk Inc

Learning Objectives

Upon completion of this activity, participants should be able to:
  • Summarize updated guideline recommendations for type 2 diabetes
  • Select guideline-recommended pharmacologic treatment(s) to achieve A1C goals while minimizing risk of adverse events such as hypoglycemia and weight gain
  • Devise a management plan for a patient with type 2 diabetes who is at high risk for hypoglycemia and who is not at target A1C goal
  • Apply tenets of shared decision making to the management of patients with type 2 diabetes

Faculty Disclosure

Primary Author

Vivian A. Fonseca, MD, FRCP

Professor of Medicine and Pharmacology
Assistant Dean for Clinical Research
Tullis Tulane Alumni Chair in Diabetes
Chief, Section of Endocrinology
Tulane University Health Sciences center
New Orleans, Louisiana

The faculty reported the following relevant financial relationship(s) during the content development process for this activity:

Vivian Fonseca, MD: Research Support, Asahi, Bayer, Endo Barrier, Gilead Sciences; Consultant, Amgen, AstraZeneca, Eli Lilly, Janssen, Novo Nordisk, Sanofi-Aventis, Takeda.

Staff Disclosure

Staff

Terrence Fagan,

Associate Scientific Director

Terrence Fagan has no real or apparent conflicts of interest to report.

Megan K. Murphy, PhD

Scientific Director

Megan Murphy, PhD, has no real or apparent conflicts of interest to report.

Jenny Schulz, PhD

Associate Managing Editor, Hepatitis
Clinical Care Options, LLC

Jenny Schulz, PhD, has no real or apparent conflicts of interest to report.

Additional Information

Participation in this self-study activity should be completed in approximately 1 hours. To successfully complete this activity and receive credit, participants must follow these steps during the period from August 04, 2016, through August 03, 2017:

1. Register online at http://www.clinicaloptions.com.
2. Read the target audience, learning objectives, and faculty disclosures.
3. Study the educational activity online or printed out.
4. Submit answers to the posttest questions and evaluation questions online.

You must receive a test score of at least 65% and respond to all evaluation questions to receive a certificate. After submitting the evaluation, you may access your online certificate by selecting the certificate link on the posttest confirmation page. Records of all CME/CE activities completed can be found on the "CME/CE Manager" page. There are no costs/fees for this activity.

Program Medium

This program has been made available online.